aspirin has been researched along with Macular Degeneration in 57 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Macular Degeneration: Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prospective data to examine the association of homocysteine with age-related macular degeneration (AMD) are limited." | 9.20 | Prospective study of plasma homocysteine level and risk of age-related macular degeneration in women. ( Buring, JE; Christen, WG; Cook, NR; Ridker, PM, 2015) |
| "To test whether alternate-day low-dose aspirin affects incidence of age-related macular degeneration (AMD) in a large-scale randomized trial of women." | 9.14 | Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. ( Buring, JE; Chew, EY; Christen, WG; Glynn, RJ, 2009) |
| "We conducted a meta-analysis of randomized controlled trials (RCTs) and observational studies to evaluate the association between aspirin use and age-related macular degeneration (AMD)." | 8.90 | Association between aspirin use and age-related macular degeneration: a meta-analysis. ( He, JJ; Lou, LX; Xu, YF; Ye, J, 2014) |
| "The aim of this review was to evaluate the evidence for an association between Aspirin use and early age-related macular degeneration (ARMD)." | 8.90 | Aspirin use and early age-related macular degeneration: a meta-analysis. ( Casson, RJ; Kahawita, SK, 2014) |
| "This commentary on the review by Christen and Chew discusses the controversy surrounding aspirin use and its association with age-related macular degeneration (AMD)." | 7.80 | Does aspirin increase the risk of age-related macular degeneration? ( Chong, EW; Guymer, RH; Robman, LD, 2014) |
| "To examine the relationship between aspirin intake and early age-related macular degeneration (AMD) among an Asian population." | 7.79 | Is aspirin intake associated with early age-related macular degeneration? The Singapore Indian Eye Study. ( Cheung, GC; Cheung, N; Mitchell, P; Tay, WT; Wang, JJ; Wong, TY, 2013) |
| "To determine whether regular aspirin use is associated with a higher risk for developing age-related macular degeneration (AMD) by using analyzed data from a 15-year prospective cohort." | 7.79 | The association of aspirin use with age-related macular degeneration. ( Liew, G; Mitchell, P; Rochtchina, E; Wang, JJ; Wong, TY, 2013) |
| "To investigate the relationship between statin and aspirin use and the risk of choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD)." | 7.72 | Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. ( Bhatt, HR; Duncan, JL; McCulloch, CE; Schwartz, DM; Wilson, HL, 2004) |
| "Prospective data to examine the association of homocysteine with age-related macular degeneration (AMD) are limited." | 5.20 | Prospective study of plasma homocysteine level and risk of age-related macular degeneration in women. ( Buring, JE; Christen, WG; Cook, NR; Ridker, PM, 2015) |
| "To test whether alternate-day low-dose aspirin affects incidence of age-related macular degeneration (AMD) in a large-scale randomized trial of women." | 5.14 | Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. ( Buring, JE; Chew, EY; Christen, WG; Glynn, RJ, 2009) |
| "We conducted a meta-analysis of randomized controlled trials (RCTs) and observational studies to evaluate the association between aspirin use and age-related macular degeneration (AMD)." | 4.90 | Association between aspirin use and age-related macular degeneration: a meta-analysis. ( He, JJ; Lou, LX; Xu, YF; Ye, J, 2014) |
| "The aim of this study was to examine whether use of regular aspirin and/or other non-steroidal anti-inflammatory drugs (NSAIDs) is associated with the development of age-related macular degeneration (AMD)." | 4.02 | Non-steroidal Anti-inflammatory Drug Use and Risk of Age-Related Macular Degeneration in the California Teachers Study. ( Bernstein, L; Coleman, AL; Deapen, D; Heck, JE; Lee, E; Liew, Z; Marshall, SF; Pinder, R; Ritz, B; Xu, X, 2021) |
| "To examine the relationship between aspirin intake and early age-related macular degeneration (AMD) among an Asian population." | 3.79 | Is aspirin intake associated with early age-related macular degeneration? The Singapore Indian Eye Study. ( Cheung, GC; Cheung, N; Mitchell, P; Tay, WT; Wang, JJ; Wong, TY, 2013) |
| "To determine whether regular aspirin use is associated with a higher risk for developing age-related macular degeneration (AMD) by using analyzed data from a 15-year prospective cohort." | 3.79 | The association of aspirin use with age-related macular degeneration. ( Liew, G; Mitchell, P; Rochtchina, E; Wang, JJ; Wong, TY, 2013) |
| "To investigate the relationship between statin and aspirin use and the risk of choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD)." | 3.72 | Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. ( Bhatt, HR; Duncan, JL; McCulloch, CE; Schwartz, DM; Wilson, HL, 2004) |
| "Add-Aspirin is a phase III, multi-centre, double-blind, placebo-controlled randomised trial with four parallel cohorts." | 2.82 | ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. ( Berkman, L; Cafferty, FH; Cameron, D; Coyle, C; Gilbert, D; Gupta, S; Kynaston, H; Langley, RE; MacKenzie, M; Pramesh, CS; Ring, A; Rowley, S; Wilson, RH, 2016) |
| "those without maculopathy but being above the age of 50 and having risk factors inducing endothelial dysfunction; 2." | 2.44 | [New possibilities in the pharmacologic prevention of age-related macular degeneration]. ( Fischer, T, 2008) |
| "The aim of this study was to evaluate the effects of chronic use of acetylsalicylic acid (ASA) and vitamin K antagonists (VKA) on the incidence of age related macular degeneration (AMD)." | 1.42 | [Does acetylsalicylic acid and vitamin K antagonists are risk factors of macular degeneration related with age?]. ( Jarmak, A; Jończyk-Skórka, K; Kowalski, J; Śliwczyńska-Rodziewicz, D, 2015) |
| " Two examples of this procedure would be the photodynamic treatment of choroidal neovasculature associated with exudative age-related macular degeneracy (AMD) where local delivery of an anti-angiogenic or an anti-inflammatory drug has been shown to be effective, or PDT of cancer where local dosing of a chemotherapeutic drug may well increase the treatment efficacy." | 1.34 | Combination therapy using aspirin-enhanced photodynamic selective drug delivery. ( Ballini, JP; Debefve, E; Konan, YN; Pegaz, B; van den Bergh, H, 2007) |
| "A therapy-resistant angle closure glaucoma following displacement of the lens-iris diaphragm due to massive choroidal and subretinal hemorrhages has rarely been reported." | 1.30 | [Acute glaucoma caused by massive subretinal hemorrhage in age-related macular degeneration and disordered thrombocyte function]. ( Hesse, L; Poller, S, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.26) | 18.7374 |
| 1990's | 1 (1.75) | 18.2507 |
| 2000's | 18 (31.58) | 29.6817 |
| 2010's | 34 (59.65) | 24.3611 |
| 2020's | 1 (1.75) | 2.80 |
| Authors | Studies |
|---|---|
| Lad, EM | 1 |
| Xu, X | 1 |
| Ritz, B | 1 |
| Coleman, AL | 1 |
| Liew, Z | 1 |
| Deapen, D | 1 |
| Lee, E | 1 |
| Bernstein, L | 1 |
| Pinder, R | 1 |
| Marshall, SF | 1 |
| Heck, JE | 1 |
| Small, KW | 1 |
| Garabetian, CA | 1 |
| Shaya, FS | 1 |
| Attal, R | 1 |
| Lazareth, I | 1 |
| Angelopoulos, G | 1 |
| Priollet, P | 1 |
| Cheung, N | 1 |
| Tay, WT | 1 |
| Cheung, GC | 1 |
| Wang, JJ | 3 |
| Mitchell, P | 3 |
| Wong, TY | 2 |
| Zhu, W | 1 |
| Wu, Y | 1 |
| Xu, D | 1 |
| Li, YH | 1 |
| Jun, B | 1 |
| Zhang, XL | 1 |
| Wang, F | 1 |
| Yu, J | 1 |
| Nowroozzadeh, MH | 1 |
| Hu, X | 1 |
| Tang, S | 1 |
| Klein, BE | 3 |
| Howard, KP | 2 |
| Christen, WG | 7 |
| Ramaswamy, SG | 1 |
| Greenberg, PB | 1 |
| Krzystolik, MG | 1 |
| Keller, DL | 1 |
| Liew, G | 2 |
| Ye, J | 2 |
| Xu, YF | 2 |
| He, JJ | 1 |
| Lou, LX | 1 |
| Kahawita, SK | 1 |
| Casson, RJ | 1 |
| Chew, EY | 4 |
| Chong, EW | 1 |
| Guymer, RH | 1 |
| Robman, LD | 1 |
| Nowak, JZ | 1 |
| Wang, W | 1 |
| Zhang, X | 1 |
| Li, L | 1 |
| Li, W | 1 |
| Chen, CZ | 1 |
| Yi, ZH | 1 |
| Zhou, YY | 1 |
| Cook, NR | 1 |
| Ridker, PM | 1 |
| Buring, JE | 4 |
| Jończyk-Skórka, K | 1 |
| Śliwczyńska-Rodziewicz, D | 1 |
| Jarmak, A | 1 |
| Kowalski, J | 1 |
| Lee, M | 1 |
| Wathier, M | 1 |
| Love, JA | 1 |
| McGeer, E | 1 |
| McGeer, PL | 1 |
| Fischer, T | 4 |
| Coyle, C | 1 |
| Cafferty, FH | 1 |
| Rowley, S | 1 |
| MacKenzie, M | 1 |
| Berkman, L | 1 |
| Gupta, S | 1 |
| Pramesh, CS | 1 |
| Gilbert, D | 1 |
| Kynaston, H | 1 |
| Cameron, D | 1 |
| Wilson, RH | 1 |
| Ring, A | 1 |
| Langley, RE | 1 |
| Michalska-Małecka, K | 1 |
| Regucka, A | 1 |
| Śpiewak, D | 1 |
| Sosnowska-Pońska, M | 1 |
| Niewiem, A | 1 |
| Glynn, RJ | 4 |
| Mascitelli, L | 1 |
| Pezzetta, F | 1 |
| Goldstein, MR | 1 |
| de Jong, PT | 1 |
| Mason, JO | 1 |
| Frederick, PA | 1 |
| Neimkin, MG | 1 |
| White, MF | 1 |
| Feist, RM | 1 |
| Thomley, ML | 1 |
| Albert, MA | 1 |
| Matsumoto, C | 1 |
| Matthan, NR | 1 |
| Wilk, JB | 1 |
| Lichtenstein, AH | 1 |
| Michael Gaziano, J | 1 |
| Djoussé, L | 1 |
| Gangnon, RE | 1 |
| Dreyer, JO | 1 |
| Lee, KE | 1 |
| Klein, R | 2 |
| Rochtchina, E | 1 |
| Kaul, S | 1 |
| Diamond, GA | 1 |
| Covinsky, KE | 1 |
| Wilson, HL | 1 |
| Schwartz, DM | 1 |
| Bhatt, HR | 1 |
| McCulloch, CE | 1 |
| Duncan, JL | 1 |
| Girgis, RA | 1 |
| McKee, HD | 1 |
| Gaynes, BI | 1 |
| Löw, U | 1 |
| Kohlhof, JK | 1 |
| Ruprecht, KW | 1 |
| Debefve, E | 1 |
| Pegaz, B | 1 |
| Ballini, JP | 1 |
| Konan, YN | 1 |
| van den Bergh, H | 1 |
| Manson, JE | 2 |
| Gaziano, JM | 1 |
| Hennekens, CH | 2 |
| Dayani, PN | 1 |
| Siddiqi, OK | 1 |
| Holekamp, NM | 1 |
| Meyer, CH | 1 |
| Eter, N | 1 |
| Horn, W | 1 |
| Hoerauf, H | 1 |
| Vine, AK | 1 |
| Poller, S | 1 |
| Hesse, L | 1 |
| Tilanus, MA | 1 |
| Vaandrager, W | 1 |
| Cuypers, MH | 1 |
| Verbeek, AM | 1 |
| Hoyng, CB | 1 |
| Ajani, UA | 1 |
| Schaumberg, DA | 2 |
| Hankinson, SE | 1 |
| Shammas, HJ | 1 |
| Milkie, CF | 1 |
| Patz, A | 1 |
| Finkelstein, D | 1 |
| Fine, SL | 1 |
| Murphy, RP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000152] | Phase 3 | 0 participants | Interventional | 1982-04-30 | Active, not recruiting | ||
| The Evaluation of Nutrition Status in Persons With Age-Related Macular Degeneration[NCT03326401] | 200 participants (Actual) | Observational | 2015-07-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for aspirin and Macular Degeneration
| Article | Year |
|---|---|
MACULAR DEGENERATION AND ASPIRIN USE.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Fibrinolytic Agents; Huma | 2017 |
Aspirin use and risk of age-related macular degeneration: a meta-analysis.
Topics: Aspirin; Humans; Macular Degeneration; Risk | 2013 |
Association between aspirin use and age-related macular degeneration: a meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Global Health; Humans; Incidence; Macular Degenera | 2014 |
Aspirin use and early age-related macular degeneration: a meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Databases, Factual; Humans; Macular Degeneration; | 2014 |
Does long-term aspirin use increase the risk of neovascular age-related macular degeneration?
Topics: Aspirin; Humans; Macular Degeneration; Observational Studies as Topic; Randomized Controlled Trials | 2014 |
Is aspirin use associated with age-related macular degeneration? A meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Macular Degeneration; Risk Assessment | 2015 |
[Pharmacological therapy of age-related macular degeneration based on etiopathogenesis].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Aspirin; Bosentan; | 2015 |
Does the use of acetylsalicylic acid have an influence on our vision?
Topics: Aspirin; Disease Progression; Humans; Macular Degeneration; Retinal Pigment Epithelium; Visual Acuit | 2016 |
[A new possible strategy for prevention and preventive treatment of age-related macular degeneration resting on recent clinical and pathophysiological observations].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Endothelium, Vascula | 2009 |
[Prevention and preventive therapy of age-related macular degeneration through the beneficial effect of treatment of endothelial dysfunction].
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Endothelium, Vascular; Humans; Hydroxymethylgluta | 2006 |
[New possibilities in the pharmacologic prevention of age-related macular degeneration].
Topics: Adrenergic Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspirin; | 2008 |
Advances in treating cystoid macular edema.
Topics: Aspirin; Cryosurgery; Humans; Indomethacin; Light Coagulation; Macular Degeneration; Prostaglandins; | 1981 |
Ophthalmology. What you can do to protect your eyes.
Topics: Alcohol Drinking; Aspirin; Eye Injuries; Eye Protective Devices; Fibrinolytic Agents; Glaucoma; Huma | 2001 |
6 trials available for aspirin and Macular Degeneration
| Article | Year |
|---|---|
Prospective study of plasma homocysteine level and risk of age-related macular degeneration in women.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Drug Combinations; Female | 2015 |
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Chemotherapy, Adjuvant; Colorect | 2016 |
Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; | 2009 |
Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; beta Carotene; Car | 2007 |
Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; beta Carotene; Cardiovascular Diseases; Double-Blind Method | 2001 |
Body mass index and the incidence of visually significant age-related maculopathy in men.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; beta Carotene; Body Mass Index; Cardiovascular Diseases; Do | 2001 |
38 other studies available for aspirin and Macular Degeneration
| Article | Year |
|---|---|
Does Aspirin Worsen Macular Degeneration in a Clinically Meaningful Way?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Eye Diseases; Humans; Macular Degeneration | 2019 |
Non-steroidal Anti-inflammatory Drug Use and Risk of Age-Related Macular Degeneration in the California Teachers Study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Longitudinal Studies; Macular Dege | 2021 |
Ranibizumab and digital ischemia.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Angioplasty; Aspirin; Combined Modality Therapy; Female; | 2018 |
Is aspirin intake associated with early age-related macular degeneration? The Singapore Indian Eye Study.
Topics: Adult; Age of Onset; Aged; Asian People; Aspirin; Cardiovascular Diseases; Cross-Sectional Studies; | 2013 |
Aspirin use and risk of macular degeneration.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Macular Degeneration; Male | 2013 |
Aspirin use and risk of macular degeneration.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Macular Degeneration; Male | 2013 |
Aspirin use and risk of macular degeneration--reply.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Macular Degeneration; Male | 2013 |
Long-term aspirin use and neovascular age-related macular degeneration: association or causation?
Topics: Aspirin; Female; Humans; Macular Degeneration; Male | 2014 |
Guideline-adherent aspirin use in individuals with age-related macular degeneration.
Topics: Aged; Aspirin; Cardiovascular Diseases; Female; Guideline Adherence; Humans; Incidence; Macular Dege | 2013 |
Is 81-mg aspirin associated with age-related macular degeneration risk?
Topics: Aspirin; Female; Humans; Macular Degeneration; Male | 2013 |
Reply: To PMID 23337937.
Topics: Aspirin; Female; Humans; Macular Degeneration; Male | 2013 |
Does aspirin increase the risk of age-related macular degeneration?
Topics: Aspirin; Humans; Macular Degeneration | 2014 |
Aspirin and age-related macular degeneration: positives versus negatives.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Fatty Acids, Unsaturated; Humans | 2014 |
Aspirin use and risk of age-related macular degeneration.
Topics: Aspirin; Humans; Macular Degeneration | 2014 |
Author response: Aspirin use and risk of age-related macular degeneration.
Topics: Aspirin; Humans; Macular Degeneration | 2014 |
[Does acetylsalicylic acid and vitamin K antagonists are risk factors of macular degeneration related with age?].
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Case-Control Studies; Causality; Comorbidity; Female; | 2015 |
Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.
Topics: Alzheimer Disease; Animals; Aspirin; Aurintricarboxylic Acid; Benzhydryl Compounds; Cats; Cells, Cul | 2015 |
Aspirin, iron loss, and age-related macular degeneration.
Topics: Aspirin; Gastrointestinal Hemorrhage; Humans; Iron Overload; Macular Degeneration | 2010 |
Aspirin and age-related macular degeneration.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Health Personnel; Humans; | 2010 |
Incidence of hemorrhagic complications after intravitreal bevacizumab (avastin) or ranibizumab (lucentis) injections on systemically anticoagulated patients.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Hu | 2010 |
Erythrocyte stearidonic acid and other n-3 fatty acids and CHD in the Physicians' Health Study.
Topics: Aged; Aging; Aspirin; beta Carotene; Case-Control Studies; Coronary Disease; Double-Blind Method; Er | 2013 |
Long-term use of aspirin and age-related macular degeneration.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Dr | 2012 |
The association of aspirin use with age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Aspirin; Australia; Cardiovascular Diseases; Cohort Studies; Female; Humans | 2013 |
Relationship of aspirin use with age-related macular degeneration: association or causation?: comment on "The association of aspirin use with age-related macular degeneration".
Topics: Aspirin; Female; Humans; Macular Degeneration; Male | 2013 |
The incremental nature of clinical research: comment on "The association of aspirin use with age-related macular degeneration".
Topics: Aspirin; Female; Humans; Macular Degeneration; Male | 2013 |
Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration.
Topics: Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Choroidal N | 2004 |
Do statins prevent age-related macular degeneration?
Topics: Aspirin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macular Degeneration | 2004 |
Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Choroidal Neovascularization; Drug Therapy, Combin | 2004 |
Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among age-related macular degeneration patients.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Choroidal Neovascularization; Humans; Hydroxymethy | 2004 |
[Does acetylsalicylic acid have a negative influence on photodynamic therapy?].
Topics: Aged; Aspirin; Choroidal Neovascularization; Drug Combinations; Female; Humans; Macular Degeneration | 2006 |
Combination therapy using aspirin-enhanced photodynamic selective drug delivery.
Topics: Animals; Aspirin; Blood Vessels; Chick Embryo; Combined Modality Therapy; Cyclooxygenase Inhibitors; | 2007 |
Safety of intravitreal injections in patients receiving warfarin anticoagulation.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticoagulants; Aptamers, Nucleotide; Aspirin; Cel | 2007 |
Incidence of ocular hemorrhages in anticoagulated patients receiving repeated intravitreal injections.
Topics: Angiogenesis Inhibitors; Anticoagulants; Aptamers, Nucleotide; Aspirin; Choroidal Neovascularization | 2008 |
[Intravitreal injections during anticoagulant treatment].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Aspirin; Bevacizumab; Cho | 2008 |
[Acute glaucoma caused by massive subretinal hemorrhage in age-related macular degeneration and disordered thrombocyte function].
Topics: Acetaminophen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Eye Enucleation; Female; Glau | 1997 |
Relationship between anticoagulant medication and massive intraocular hemorrhage in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Drug Prescriptions; Eye Hemorrhage; Female; Humans | 2000 |
Does aspirin prevent postoperative cystoid macular edema?
Topics: Aspirin; Humans; Lenses, Intraocular; Macular Degeneration; Postoperative Care; Premedication | 1979 |
The role of fluorescein angiography in national collaborative studies.
Topics: Aspirin; Choroid; Clinical Trials as Topic; Diabetic Retinopathy; Fluorescein Angiography; Forecasti | 1986 |